Per Sauerberg

2.5k citations

74 papers · 2.0k indexed · h-index 27

Cellular and Molecular Neuroscience top 2%
- Neuroscience and Neuropharmacology Research 18
- Neuropeptides and Animal Physiology 17
- Neurotransmitter Receptor Influence on Behavior 6
Molecular Biology top 5%
- Receptor Mechanisms and Signaling 45
- Peroxisome Proliferator-Activated Receptors 17
- Pharmacological Receptor Mechanisms and Effects 6
Pharmacology top 5%
Biological Psychiatry top 10%
Biochemistry top 5%
Physiology
- Adipose Tissue and Metabolism 8
- Adenosine and Purinergic Signaling 7

Co-authors: Malcolm J. Sheardown Lone Jeppesen Michael D.B. Swedberg Harlan E. Shannon Jan Fleckner Preben H. Olesen Charles H. Mitch Anders Fink‐Jensen
Cited by: Cellular and Molecular Neuroscience Molecular Biology Pharmacology
Journals: Journal of Medicinal Chemistry (14 papers)Life Sciences (12 papers)Bioorganic & Medicinal Chemistry Letters (8 papers)
Partner nations: Denmark United States Australia

In The Last Decade

Per Sauerberg

73 papers receiving 1.9k citations

Peers

Countries citing papers authored by Per Sauerberg

Since Specialization

Citations

This map shows the geographic impact of Per Sauerberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Sauerberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Sauerberg more than expected).

Fields of papers citing papers by Per Sauerberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Sauerberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Sauerberg. The network helps show where Per Sauerberg may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Per Sauerberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Per Sauerberg Line = papers co-authored together Per Sauerberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls PLoS ONE ·Lotte Simonsen,Jesper Lau,Thomas Kruse,Tingqing Guo,Akhmad Maulana Effendi,Jacob Jeppesen,Kristoffer Niss,Per Sauerberg,Kirsten Raun,Charlotta Dornonville de la Cour	2022	26
2	Structure–Activity Relationships for Negative Allosteric mGluR5 Modulators ChemMedChem ·mohamed Ashraf Abdelfattah Mohamed Hodhod,Kasper Harpsøe,E.-M. Fahrner-Tutsek,Jesper Mosolff Mathiesen,Christina Mølck,David E. Gloriam,何冬林,Michelle A. Uberti,Søren Nielsen,Birgitte Nielsen,Hans Bräuner‐Osborne,Per Sauerberg,Rasmus P. Clausen,Ulf Madsen	2012	16
3	PPARδ agonists have opposing effects on insulin resistance in high fat‐fed rats and mice due to different metabolic responses in muscle British Journal of Pharmacology ·Ji‐Ming Ye,赵小龙,Nigel Turner,Xiao‐Yi Zeng,Haiyan Li,Gregory J. Cooney,Erik Max Wulff,Per Sauerberg,Edward W. Kraegen	2011	23
4	Improved insulin sensitivity and islet function after PPARδ activation in diabetic db/db mice European Journal of Pharmacology ·Maria Sörhede Winzell,Erik Max Wulff,Grith Skytte Olsen,Per Sauerberg,C. F. Gotfredsen,Bo Åhrén	2009	34
5	Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-γ) agonist balaglitazone European Journal of Pharmacology ·Philip J. Larsen,Kirsten Lykkegaard,Leif K. Larsen,Jan Fleckner,Per Sauerberg,Karsten Wassermann,Erik Max Wulff	2008	34
6	Structural Proof of a Dimeric Positive Modulator Bridging Two Identical AMPA Receptor-Binding Sites Chemistry & Biology ·mohamed Ashraf Abdelfattah Mohamed Hodhod,Kasper Harpsøe,J.S. Kastrup,梦迪,Darryl S. Pickering,Jared Clay Hogan,Rasmus P. Clausen,Michael Gajhede,Per Sauerberg,Tommy Liljefors,Ulf Madsen	2007	52
7	Novel selective PPARδ agonists: Optimization of activity by modification of alkynylallylic moiety Bioorganic & Medicinal Chemistry Letters ·Omar Samateh,Per Sauerberg,John P. Mogensen,Lingting Ji,Claus Jeppesen,Ingrid Pettersson,S. Di Ciolo	2007	10
8	Design of potent PPARα agonists Bioorganic & Medicinal Chemistry Letters ·Per Sauerberg,John P. Mogensen,Lone Jeppesen,Paul S. Bury,Jan Fleckner,Grith Skytte Olsen,Claus Jeppesen,Erik Max Wulff,S. Di Ciolo,Omar Samateh,Zdeněk Polívka,Ingrid Pettersson	2007	13
9	Prediction of PPAR-α ligand-mediated physiological changes using gene expression profiles Journal of Lipid Research ·Klaus Stensgaard Frederiksen,Erik Max Wulff,Per Sauerberg,John P. Mogensen,Lone Jeppesen,Jan Fleckner	2004	53
10	Identification of hepatic transcriptional changes in insulin-resistant rats treated with peroxisome proliferator activated receptor-alpha agonists Journal of Molecular Endocrinology ·ناهید شبانیان بروجنی,D F GRADY,Karsten Wassermann,Per Sauerberg,Jan Fleckner	2003	27
11	Central muscarinic inhibition of lower urinary tract nociception Brain Research ·Karl B. Thor,Mark Muhlhauser,Per Sauerberg,Harlan E. Shannon,Johannes P. Springer	2000	11
12	Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane European Journal of Pharmacology ·Poneh Ebrahimi,Harlan E. Shannon,Kurt Rasmussen,Neil W. DeLapp,Charles H. Mitch,John S. Ward,David O. Calligaro,Gabriella Mangione,Malcolm J. Sheardown,Preben H. Olesen,Michael D.B. Swedberg,Per Sauerberg,Anders Fink‐Jensen	1998	53
13	Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects Brain Research ·Frank P. Bymaster,O. HUJII,Steven Peters,Wei Zhang,John S. Ward,Charles H. Mitch,David O. Calligaro,Celia A. Whitesitt,Neil W. DeLapp,Harlan E. Shannon,Karin Rimvall,Lone Jeppesen,Malcolm J. Sheardown,Anders Fink‐Jensen,Per Sauerberg	1998	56
14	Pharmacology of Butylthio[2.2.2] (LY297802/NNC11-1053): A Novel Analgesic with Mixed Muscarinic Receptor Agonist and Antagonist Activity Journal of Pharmacology and Experimental Therapeutics ·Harlan E. Shannon,Malcolm J. Sheardown,Frank P. Bymaster,David O. Calligaro,Neil W. DeLapp,J. S. Gidda,Abhinaw Sai Erri Pradeep,Barry D. Sawyer,Peter W. Stengel,John S. Ward,David T. Wong,Preben H. Olesen,Peter D. Suzdak,Per Sauerberg,Michael D.B. Swedberg	1997	22
15	Synthesis and structural determination of stereoisomers of muscarinic ligands of the (3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicycloalkane type Chirality ·Preben H. Olesen,Per Sauerberg,A Gerth,Svend Treppendahl,dr.Rawaa Mahmoud Hussain,Jack B. Deeter,John S. Ward,Charles H. Mitch,Victor X. Díaz-Estrada	1997	5
16	Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines Journal of Medicinal Chemistry ·Per Sauerberg,Preben H. Olesen,M. Hamalengwa,Svend Treppendahl,Malcolm J. Sheardown,Tage Honoré,Charles H. Mitch,John S. Ward,Andrew Pike	1992	131
17	Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure-activity relationships Journal of Medicinal Chemistry ·Per Sauerberg,Daniel Jesús Tan Lam,Lone Nielsen,Malcolm J. Sheardown,Tage Honoré	1991	40
18	Cyclic carbamate analogs of pilocarpine Journal of Medicinal Chemistry ·Per Sauerberg,Jake Y. Chen,Elizabeth WoldeMussie,Henry Rapoport	1989	20
19	Bioisosteres of arecoline as novel CNS-active muscarinic agonists. PubMed ·Povl Krogsgaard‐Larsen,E. FALCH,Per Sauerberg,Stephen B. Freedman,Villarreal Oscar D.,Eddi Meier	1988	2
20	Heterocyclic muscarinic agonists. Synthesis and biological activity of some bicyclic sulfonium arecoline bioisosteres Journal of Medicinal Chemistry ·Per Sauerberg,Erik Falch,Eddi Meier,K. J. Kadow,Povl Krogsgaard‐Larsen	1988	10

About Per Sauerberg

Per Sauerberg is a scholar working on Cellular and Molecular Neuroscience, Physiology, Molecular Biology, Toxicology and Physiology, having authored 74 papers that have together received 2.0k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (45 papers), Neuroscience and Neuropharmacology Research (18 papers), Peroxisome Proliferator-Activated Receptors (17 papers), Neuropeptides and Animal Physiology (17 papers), Adipose Tissue and Metabolism (8 papers), Adenosine and Purinergic Signaling (7 papers), Pharmacological Receptor Mechanisms and Effects (6 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (887 citations), Molecular Biology (1.5k citations), Pharmacology (247 citations), Biological Psychiatry (34 citations) and Biochemistry (92 citations). Per Sauerberg has collaborated with scholars based in Denmark, United States and Australia. Frequent co-authors include Malcolm J. Sheardown, Lone Jeppesen, Michael D.B. Swedberg, Harlan E. Shannon, Jan Fleckner, Preben H. Olesen, Charles H. Mitch, Anders Fink‐Jensen, Frank P. Bymaster and John S. Ward. Their work appears in journals such as Journal of Medicinal Chemistry, Life Sciences, Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact